ArticleMolecular therapy. Nucleic acids2024

Splice-switching antisense oligonucleotide controlling tumor suppressor REST is a novel therapeutic medicine for neuroendocrine cancer.

Keishiro Mishima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.